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Seven small-scale drinking water purification devices were evaluated for their capacity to eliminate botuli-
num neurotoxin (BoNT) type B from drinking water. Influent water inoculated with toxic Clostridium botulinum
cultures and effluent purified water samples were tested for the presence of BoNT by using a standard mouse
bioassay and two commercial rapid enzyme immunoassays (EIAs). The water purification devices based on
filtration through ceramic or membrane filters with a pore size of 0.2 to 0.4 m or irradiation from a
low-pressure UV-lamp (254 nm) failed to remove BoNT from raw water (reduction of <0.1 log10 units). A single
device based on reverse osmosis was capable of removing the BoNT to a level below the detection limit of the
mouse bioassay (reduction of >2.3 log10 units). The rapid EIAs intended for the detection of BoNT from
various types of samples failed to detect BoNT from aqueous samples containing an estimated concentration
of BoNT of 396,000 ng/liter.
Data on the purification capacities of various water purifi-
cation devices and techniques are essential for the assessment
of drinking water safety. Water sources and drinking water
supply systems can become fecally contaminated but may also
be targets for bioterrorism or sabotage (8, 9, 20, 22). Botuli-
num neurotoxins (BoNT; types A to G) produced by Clostrid-
ium botulinum and by some other related clostridia are the
most potent biotoxins known, and as tasteless and odorless
lethal compounds they would generate great concern if weap-
onized (5, 13, 27).
Several small-scale devices from different manufacturers are
commercially available for drinking water purification. These
devices, mostly based on filtration through ceramic or mem-
brane filters, are needed especially by soldiers, hikers, or work-
ers of aid organizations operating in primitive wilderness or
under disaster conditions (6). Similar filters are also marketed
for point-of-use in single households. To ensure consumer
safety, it is essential to compare the microbial and chemical
purification capacities of different devices through indepen-
dent evaluation tests (12, 23). Data are available on the puri-
fication capacity of some filters, but usually these data are
based on the capacity of the filters to remove microbial organ-
isms, e.g., Escherichia coli, coliforms, or Cryptosporidium oo-
cysts (15, 26, 28). There are some reports in which water
purification devices or techniques were tested for elimination
of microbial toxins, mainly cyanobacterial toxins (1–3, 17, 18,
25, 29, 33).
Free chlorine at a concentration of 5 mg/liter of water (5
ppm) for 30 min (32) and heating water at 80°C for 30 min (19)
were shown to be effective for inactivation of BoNT. Assump-
tions on the capacity of reverse osmosis to remove BoNT from
drinking water have been made (32), but no research to test
this capacity has been performed. Reverse osmosis is assumed
to eliminate BoNT effectively based of the 150-kDa molecular
size of the toxin.
Rapid and sensitive tests are needed for BoNT detection
under field conditions as well as for rapid screening of suspect
samples (7). At present, the few rapid tests available have not
shown sufficient sensitivity or specificity to replace the standard
mouse bioassay, which remains the only standard method
available for BoNT detection (4, 34). Apart from being time-
consuming, the mouse bioassay poses ethical, economic, and
safety concerns. Some enzyme-linked immunosorbent assays
and enzyme immunoassays (EIAs) are available that show sen-
sitivity similar to sensitivity level of the mouse bioassay (10, 11,
16, 35).
The aim of the present study was to obtain data on the
capacity of commercial water purification devices based on
various methods to eliminate BoNT from intentionally con-
taminated drinking water. Furthermore, two commercially
available rapid EIAs for BoNT detection were evaluated in
comparison to the standard mouse bioassay.
MATERIALS AND METHODS
Inoculated raw water. A total of 70 liters of tap water from the municipal
drinking water supply system of Helsinki was stored in an open plastic container
for 24 h to reduce the free chlorine concentration. Seven proteolytic C. botulinum
strains producing BoNT type B (Table 1) were cultured separately in 100 ml of
tryptone-peptone-glucose-yeast extract liquid broth medium (Oxoid Ltd., Bas-
ingstoke, Hampshire, United Kingdom) anaerobically at 37°C for 72  2 h,
followed by subculture at 37°C for 16 h. The broth cultures (seven cultures, 100
ml each) were added to the tap water (influent water).
Water purification devices and testing. The water purification devices were
selected from among commercially available products based partly on the suit-
ability for field operation. Six devices, representing various types of filters and
purification methods, were selected from four manufacturers (Table 2). In ad-
dition, an experimental sand filter was developed (Table 2). All devices were
portable (weight, 10 kg) and functional without electricity or chemical supple-
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mentation. The devices were used manually according to the instructions of the
manufacturer. Prior to use, each device was rinsed with 1 to 2 liters of sterile
water. A total of 3 liters of purified effluent water was produced with each device
from inoculated influent water. The purified effluent water samples were col-
lected in sterile glass bottles for further investigation.
Sampling. From the inoculated influent water the following samples were
taken prior to using the purification devices: a 100-ml sample for total aerobic
bacterial count; a 200-ml sample for total and free chlorine, conductivity, and pH
analyses; and two 200-ml samples for BoNT analyses. From the purified effluent
water produced by each device, a 100-ml sample for total aerobic bacterial count,
a 200-ml sample for conductivity and pH, and two 200-ml samples for BoNT
analyses were taken.
Bacteriological and physicochemical analysis. As a process indicator, the total
aerobic count was analyzed by using 3 M Petrifilm aerobic count plates (3M
Corp., St. Paul, Minn.) of 1-ml influent and effluent water samples. The plates
were incubated at 35°C for 24  2 h. Free and total chlorine were analyzed by
using the Spectroquant Colorimeter Picco Cl2 spectrophotometer (Merck
KGaA, Darmstadt, Germany). Temperature (Delta Ohm HD8601P; Padua, It-
aly), pH (Eutech Cybernetics pHScanWP2; Singapore, Republic of Singapore),
and conductivity (HACH Model C0150 conductivity meter; Loveland, Colo.)
were measured with portable devices.
BoNT analysis. BoNT was analyzed by using a mouse bioassay (24, 31) with
the permission of the State Provincial Office of Southern Finland. Samples from
influent water inoculated with toxic C. botulinum cultures and purified effluent
waters were sterile filtered through 0.45-m-pore-size bacteriological membrane
filters and diluted 10-fold (101, 102, 103, 104, and 105). One undiluted
sample from inoculated influent water was heated at 100°C for 10 min to destroy
the toxin prior to testing for possible nonspecific reactions in the mouse bioassay.
A 0.8-ml volume of each undiluted and diluted sample and of heated sample was
injected intraperitoneally into two 20-g laboratory mice. The mice were observed
for typical symptoms of botulism for 4 days. The test results were used to
estimate the BoNT concentration in the water samples and a 50% lethal dose of
1.2 ng of BoNT type B per kg of body weight was used in this estimation (13).
Two commercial rapid EIAs (Bot Tox BioThreat Alert Test Strip, Tetracore,
Inc., Gaithersburg, Md., and BADD BoNT Rapid Detection Kit, Osborn Scien-
tific Group, Lakeside, Ariz.) were used to further analyze the undiluted and
diluted samples of inoculated influent water and undiluted samples of purified
effluent water. The tests were qualitative and based on the use of dye-labeled
anti-botulinum toxin antibodies, which in the presence of BoNT were intended
to appear as visible colored lines. Both tests were performed according to the
manufacturers’ instructions. A 0.5-ml volume of sample was diluted with 0.5 ml
of the buffer solution provided with the test kits, and a 0.15-ml volume of this
dilution was dispensed onto the sample port of the test strips. The tests were
interpreted as positive if two colored lines appeared in the test strip within 15
min: one in the test or sample location and one in the control location. The tests
were interpreted as negative if only the control line appeared and as invalid if no
line appeared at the control location.
Determination of purification capacities. The purification capacities of the
devices were calculated as logarithmic (log10) reductions in concentrations of
analyzed parameters (total aerobic count, conductivity, and estimated concen-
tration of BoNT) between undiluted inoculated influent water and undiluted
purified effluent water samples. The reduction in log10 units was calculated by
using the following formula: log10 reduction  log10 (Ni/Ne), where Ni is the
concentration in influent water before purification and Ne is the concentration in
purified effluent water after purification.
If no aerobic bacteria were detected in the undiluted purified effluent water
sample, the log10 reduction was estimated by using an aerobic bacteria count of
1 CFU/ml of sample. If the mouse bioassay was negative for BoNT in the
undiluted purified effluent water sample, the maximum concentration of BoNT
in the sample was estimated by using the detection limit of the mouse bioassay
and the log10 reduction calculated as above.
RESULTS
Two of the water purification devices tested were able to
eliminate some or all of the BoNT type B from the inoculated
influent water (Tables 3 and 4). The device based on reverse
osmosis removed 2.3 log10 units of BoNT to the level below
the detection limit of the mouse bioassay, and the experimental
sand filter reduced the level of toxin by 0.3 to 1.3 log10 units.
The devices based merely on physical filtration through ce-
ramic or membrane filters through 0.2- to 0.4-m pores were
not able to remove BoNT from the inoculated influent water
(reduction, 0.1 log10 units), nor was UV irradiation from the
low-pressure lamp able to destroy the toxin. All purification
devices except for the sand filter reduced the level of total
TABLE 1. Proteolytic C. botulinum type B strains used in the study
Strain name (alternative name) Origin Sourcea
ATCC 7949 (Hegarty 213 B) Canned onions ATCC
ATCC 17841 (McClung 1347 B) NKb ATCC
93/24 (FT243) NK IFR




a ATCC, American Type Culture Collection; IFR, Institute of Food Research,
Norwich, United Kingdom; DFEH, Department of Food and Environmental
Hygiene, University of Helsinki, Finland.
b NK, not known.
TABLE 2. Water purification devices tested for elimination of botulinum toxin type B from drinking water






Katadyn Combi (Katadyn Products Inc.,
Wallisellen, Switzerland)
Ceramic filter (pores, 0.2 m); activated carbon 72 50,000
Katadyn Pocket (Katadyn Products Inc.) Ceramic filter (pores, 0.2 m) 72 50,000
Katadyn Survivor MROD-35 (Katadyn
Products Inc.)
Reverse osmosis 4.5 NAb
WaterWorksII (Mountain Safety
Research, Seattle, Wash.)
Ceramic filter (pores, 0.3 m); activated carbon;
membrane (pores, 0.2 m)
40 NA
Nerox 02 Filter (Nerox Filter Oy,
Tampere, Finland/Plastec AS, Gjovik,
Norway)
Membrane (pores, 0.4 m) 5 2,500
Wedeco Aquada 4 (Wedeco AG Water
Technology; Du¨sseldorf, Germany)
Low-pressure ultraviolet lamp (254-nm radiation) 3,870 NA
Sand filter (experimental device) Sand filtration (0.6–1.2 mm silica sand granules;
column height, 20 cm; column diameter, 20 cm)
30 NA
a Data according to the manufacturer.
b NA, data not available.
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aerobic count from the inoculated water by 3.3 log10 units
(sand filter, reduction by 0.8 log10 units). The device based on
reverse osmosis was the only device able to reduce conductivity
during the purification process (reduction by 1.6 log10 units).
The total aerobic count in the inoculated influent water was
2,000 CFU/ml of water, conductivity was 322.2 S/cm, and the
concentration of free and total chlorine was 0.01 mg/liter.
The results for detection of BoNT with the standard mouse
bioassay and commercial rapid tests are presented in Table 3.
The BoNT concentrations were extrapolated from the mouse
bioassay results to be in the range of 3,960 to 5,985 ng/liter in
undiluted inoculated influent water and 100-fold higher in the
tryptone-peptone-glucose-yeast extract broth used for inocu-
lating the influent water. Both commercial rapid EIA kits de-
termined that all the samples that were positive in the mouse
bioassay were negative for BoNT. All samples negative in the
mouse bioassay were also negative in the rapid EIAs.
DISCUSSION
The testing of the water purification devices produced in-
formation crucial to the assessment of drinking water safety
and security. Based on the present study and some suggestive
results from earlier studies (18), the only technique available
for portable devices capable of eliminating BoNT from drink-
ing water is reverse osmosis. To some extent sand filtration
could be effective in reducing BoNT concentration, as sug-
gested here as well as in studies on microcystin removal, but
TABLE 3. Detection of botulinum toxin type B in C. botulinum culture broth, inoculated influent water, and purified effluent waters
Source of sampling Dilution level
Detection of botulinum toxin type Ba Concentration of botulinum
toxin in undiluted sample
as estimated by mouse
bioassayb (ng/liter)
Mouse bioassay
(no. of mice surviving/





C. botulinum cultures in TPGY
brothc
Undiluted Positive (0/2) Negative Negative 396,000–598,500
Influent water inoculated with
C. botulinum cultures,
heated (100°C, 10 min)
Undiluted Negative (2/2) Negative Negative 30
Influent water inoculated with Undiluted Positive (0/2) Negative Negative 3,960–5,985
C. botulinum cultures 101 Positive (0/2) Negative Negative
102 Positive (0/2) Negative Negative
102.12 Positive (0/2) ND ND
102.30 Negative (2/2) ND ND
102.60 Negative (2/2) ND ND
103 Negative (2/2) Negative Negative
Effluent from Katadyn Combi Undiluted Positive (0/4) Negative Negative 3,000–30,000
(Katadyn Products Inc. 101 Positive (0/4) ND ND
Wallisellen, Switzerland) 102 Positive (0/4) ND ND
103 Negative (4/4) ND ND
Effluent from Katadyn Pocket Undiluted Positive (0/4) Negative Negative 3,000–30,000
(Katadyn Products Inc.) 101 Positive (0/4) ND ND
102 Positive (2/4) ND ND
103 Negative (4/4) ND ND
Effluent from Katadyn Survivor Undiluted Negative (4/4) Negative Negative 30
MROD-35 (Katadyn 101 Negative (4/4) ND ND
Products Inc.) 102 Negative (4/4) ND ND
103 Negative (4/4) ND ND
Effluent from WaterWorksII Undiluted Positive (0/4) Negative Negative 3,000–30,000
(Mountain Safety Research, 101 Positive (0/4) ND ND
Seattle, Wash.) 102 Positive (0/4) ND ND
103 Negative (4/4) ND ND
Effluent from Nerox 02 filter Undiluted Positive (0/4) Negative Negative 3,000–30,000
(Nerox Filter Oy, Tampere, 101 Positive (0/4) ND ND
Finland/Plastec AS, Gjovik 102 Positive (0/4) ND ND
Norway) 103 Negative (4/4) ND ND
Effluent from Wedeco Undiluted Positive (0/4) Negative Negative 3,000–30,000
Aquada4 (Wedeco AG 101 Positive (0/4) ND ND
Water Technology, 102 Positive (0/4) ND ND
Du¨sseldorf, Germany) 103 Negative (4/4) ND ND
Effluent from sand filter Undiluted Positive (0/4) Negative Negative 300–3,000
(experimental device) 101 Positive (0/4) ND ND
102 Negative (4/4) ND ND
103 Negative (4/4) ND ND
a Bot Tox BioThreat Alert Test Strip (Tetracore, Inc., Gaithersburg, Md.); BADD Botulinum Toxin Rapid Detection Kit (Osborn Scientific Group, Lakeside, Ariz.);
ND, not done.
b Concentration estimated by using the result of the mouse bioassay at various dilutions when 0.8-ml volume of sample was injected intraperitoneally into 20-g mice
and by using an estimate of 1.2 ng/kg of body weight as the 50% lethal dose of botulinum toxin for mice.
c A mixture of seven toxic C. botulinum type B strains (Table 2) enriched in tryptone-peptone-glucose-yeast extract (TPGY) broth anaerobically at 35°C for 72 
16 h.
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this most probably is strongly dependent on the thickness of
the sand bed and properties of the sand used (21, 25).
In the present study, the 254-nm UV irradiation produced by
the low-pressure lamp was not able to degrade BoNT in the
water. Some studies indicated that direct sunlight can degrade
BoNT by 90% in 1 h and 100% in 3 h (30). The degradation
process probably required broad-spectrum UV irradiation cou-
pled with oxidative spectrum produced by high-pressure UV
lamps. Activated carbon combined with filtration through ce-
ramic filters did not affect toxin removal in this study. A single
previous study showed activated carbon to be effective against
BoNT type A in water samples (14), but the removal was
apparently due to the amount and type of activated carbon
used as well as to the flow rate of the water and contact time
with the carbon. In the present study, the activated carbon was
either in the form of a thin layer or in a relatively small
cartridge. Taking into account the purification techniques of
individual filters, the results of aerobic bacteria removal and
reduction in conductivity coincided with their theoretical pu-
rification capacities and with the results of earlier studies on
some other drinking water purification filters (18, 28).
The rapid EIAs for detection of BoNT showed poor perfor-
mance compared with the results of the standard mouse bio-
assay. Even the broth with toxic C. botulinum cultures at esti-
mated BoNT concentrations of 396,000 to 598,500 ng/liter
appeared to be negative for BoNT when evaluated with the
rapid tests. It can be estimated from the toxicological data that
only 1.2 to 1.8 ml of this broth constitutes the oral lethal dose
for a 70-kg human being (4, 13, 27). The failure to detect
BoNT is unexpected, since the estimated concentration of
BoNT in this test was similar to or higher than the detection
limits of the tests reported by the manufacturers. The inten-
tional contamination of drinking water and water supply sys-
tems will apparently result in concentrations remarkably lower
in distributed drinking water than in pure bacterial culture (8).
However, the total intake of the toxin can still cause symptoms
or death due to the total amount of water ingested. Therefore,
the usefulness of these rapid tests is very limited due to their
high detection limit and failure to detect lethal concentrations
of toxin in drinking water. The negative test results will be
misleading and may result in casualties if BoNT is intentionally
released into drinking water supplies.
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